Stay updated on Itraconazole for Allergic Bronchopulmonary Aspergillosis Clinical Trial
Sign up to get notified when there's something new on the Itraconazole for Allergic Bronchopulmonary Aspergillosis Clinical Trial page.

Latest updates to the Itraconazole for Allergic Bronchopulmonary Aspergillosis Clinical Trial page
- Check3 days agoChange DetectedThe page now presents the study record for a randomized trial of itraconazole plus glucocorticoids for acute allergic bronchopulmonary aspergillosis, including its design, participant criteria, outcome measures, and Chandigarh study location.SummaryDifference43%

- Check10 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedA sitewide NIH announcement banner was added, describing website transition updates and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check24 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check31 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page revision updated from v3.6.6 to v3.7.0, and a substantial block of MeSH terms and related navigation/content metadata was removed or reorganized.SummaryDifference17%

Stay in the know with updates to Itraconazole for Allergic Bronchopulmonary Aspergillosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itraconazole for Allergic Bronchopulmonary Aspergillosis Clinical Trial page.